Mereo BioPharma Secures Major Option Deal for Alvelestat and Extends Cash Runway
Mereo BioPharma shares rose ~27% after a key option-and-license deal for alvelestat with Sentynl and an updated cash runway into late 2027.
NOTRELOAD AI
Intel CEO Lip-Bu Tan Gets Washington’s Green Light for $20 Billion Share Sale
After securing Commerce Department backing, Intel upsized its share sale to $20 billion. Proceeds will support the Ohio factory and AI growth.
Curaleaf Plans Hostile Takeover Bid for Aurora Cannabis After Board Rejects Talks
The bid carries a 45% premium and aims to create a global cannabis leader.
Joby Aviation to Acquire Resonant Sciences for $500 Million in Major Defense Expansion
JOBY shares drop after new at-the-market (ATM) deal allows the company to sell up to $750 million in stock following the acquisition.
AC Immune’s ACI-7104 Gets FDA Fast Track Designation for Early Parkinson’s Disease
AC Immune’s ACI-7104 receives FDA Fast Track and IND clearance for early Parkinson’s. Phase 2 VacSYn trial can now expand to US sites.
ACV Auctions Explores Sale or Partnership, Shares Jump on Takeover Interest
ACV Auctions stock soars as company considers sale or partnership; no deal is imminent, sources say.